Trial Profile
A randomized phase III study to compare conventional chemotherapy (CHOEP-14) + rituximab vs high-dose chemotherapy followed by autologous stem cell transplantation (Mega-CHOEP-21) + rituximab in younger patients with aggressive NHL
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 29 May 2023
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Vincristine
- Indications B-cell lymphoma
- Focus Therapeutic Use
- Acronyms R-MegaCHOEP
- 13 Mar 2020 Results comparing International prognostic indices in diffuse large B-cell lymphoma using different trials published in the Blood
- 06 Nov 2019 Results of 10-year follow-up of this study, were released in the 61st Annual Meeting and Exposition of the American Society of Hematology.
- 01 Aug 2017 Results of pooled data of clinical impact of the cell-of-origin classification and the MYC/ BCL2 dual expresser status in diffuse large B-cell lymphoma treated within two prospective clinical trials (RICOVER-60 and R-MegaCHOEP) of the German high-grade non-Hodgkin's lymphoma study group were, published in the Journal of Clinical Oncology.